Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04076579
Title Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Michigan Rogel Cancer Center
Indications

liposarcoma

sarcoma

leiomyosarcoma

Therapies

Olaparib + Trabectedin

Age Groups: adult | senior | child
Covered Countries USA

Facility Status City State Zip Country Details
University of Michigan Rogel Cancer Center Recruiting Ann Arbor Michigan 48109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field